Overview

Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
0
Participant gender:
Male
Summary
The purpose of the study is to determine the feasibility of providing buprenorphine maintenance to opioid-dependent offenders in a jail setting and of transitioning those patients to buprenorphine maintenance in the community after their release.
Phase:
Phase 1/Phase 2
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
National Development and Research Institutes, Inc.
Collaborators:
National Institute on Drug Abuse (NIDA)
New York City Department of Health and Mental Hygiene
Western Michigan University
Treatments:
Buprenorphine
Methadone
Criteria
Inclusion Criteria:

- opioid dependent patients who meet eligibility requirements for the KEEP program,

- patients serving sentences who will remain confined for at least 10 days but less than
90 days in the EMTC facility (all male) at Rikers,

- willingness to accept buprenorphine treatment,

- expected to reside in New York City after release

- 18-65 years of age

Exclusion Criteria:

- receiving methadone treatment in the community at sentencing and remanded to Rikers

- took non-prescribed 'street methadone' within last 3 days

- currently receiving more than 20mg/day methadone

- current psychotic symptoms (e.g., schizophrenia, schizoaffective disorder) requiring
referral for mental health intervention, or current treatment with antipsychotic
medication)

- HIV infection with T lymphocytes less than 200 per mm of blood and/or presence of a
serious opportunistic infection requiring treatment, or receiving the HIV medication
atazanavir.

- unable to complete English language interview